# Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets

> **NCT05111028** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Bloodworks** · enrollment: 10 (actual)

## Conditions studied

- Reversal of Platelet Aggregation Inhibitors

## Interventions

- **BIOLOGICAL:** Autologous Room Temperature stored Platelet transfusion
- **BIOLOGICAL:** Autologous Cold Stored Platelet transfusion

## Key facts

- **NCT ID:** NCT05111028
- **Lead sponsor:** Bloodworks
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-20
- **Primary completion:** 2021-11
- **Final completion:** 2021-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111028, "Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT05111028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*